Status:
RECRUITING
Effect of Menthol on ENDS Users' Addiction and Exposure
Lead Sponsor:
Florida International University
Conditions:
Electronic Cigarette Use
Eligibility:
All Genders
21-35 years
Phase:
NA
Brief Summary
The use of electronic nicotine delivery systems (ENDS; e-cigarettes) has reached epidemic levels among young people in the United States (US). ENDS heat and vaporize a nicotine-containing liquid to pr...
Detailed Description
The use of electronic nicotine delivery systems (ENDS; e-cigarettes) has reached epidemic levels among young people in the US. While estimates vary, ENDS have become the leading tobacco product used b...
Eligibility Criteria
Inclusion
- Generally healthy individuals (determined by physical examination).
- Age of 21-35 years.
- Is willing to provide informed consent.
- Is willing to attend the lab as required by the study protocol.
- E-cigarette users (defined as using e-cigarette either daily or occasionally in the past 30 days)
- Have abstained from e-cigarette use for 12 hours prior to each session
Exclusion
- Report smoking cigarettes regularly (\> 5 cigarettes/month in the past year).
- Report regular use of any other tobacco/nicotine product (e.g., e-cig, pipes, cigars) in the past year.
- Women who are breast-feeding or test positive for pregnancy (by urinalysis at screening).
- Individuals with self-reported history of chronic disease or psychiatric conditions.
- Individuals with history of or active cardiovascular disease, low or high blood pressure, seizures, and regular use of prescription medications (other than vitamins or birth control).
- Individuals that report current THC (marijuana) smoking/vaping.
- Individuals that report current EVALI or COVID-19 related symptoms (i.e., cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhea, fever, chills, or weight loss)
- Individuals that have or have been exposed to COVID-19 in the last 14 days.
Key Trial Info
Start Date :
June 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05338801
Start Date
June 22 2022
End Date
March 31 2027
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida International University
Miami, Florida, United States, 33199